Evidence map›Paper›PMID 23708290›Full record

ArticleNature medicine2013

Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.

Edward T Chouchani, Carmen Methner, Sergiy M Nadtochiy, Angela Logan, Victoria R Pell, Shujing Ding, Andrew M James, Helena M Cochemé, Johannes Reinhold, Kathryn S Lilley and 8 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 353 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
353citing papers in PubMed, 1 pooled it
33.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

353 citing papers in PubMed, 1 synthesis or guideline pooled it, 607 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Global conformations ofScience advances · 2025
    Article
  15. Review
  16. Article
  17. Low oxidative stress during mitochondrial recovery from anoxia in Artemia franciscana, an invertebrate extremophile.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2025
    Article
  18. Article
  19. Review
  20. Article

293 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Edward T ChouchaniMedical Research Council Mitochondrial Biology Unit, Cambridge, UK.
Carmen Methner
Sergiy M Nadtochiy
Angela Logan
Victoria R Pell
Shujing Ding
Andrew M James
Helena M Cochemé
Johannes Reinhold
Kathryn S Lilley
Linda Partridge
Ian M Fearnley
Alan J Robinson
Richard C Hartley
Robin A J Smith
Thomas Krieg
Paul S Brookes
Michael P Murphy
Medical Research Council · GBMax Planck Society · DEMRC Mitochondrial Biology Unit · GBUniversity of Rochester Medical Center · USAddenbrooke's Hospital · GBUniversity of Cambridge · GBUniversity of Glasgow · GB

Funding

SIRT1, Nitro-Lipids and CardioprotectionR01HL071158 · NHLBI · UNIVERSITY OF ROCHESTER · PI BROOKES, PAUL S · 2003 to 2025
$7.7M
Biotechnology and Biological Sciences Research Council BB/I012923British Heart Foundation PG/12/42/29655CIHRMedical Research Council MC_U105663142Medical Research Council MC_U105674181NHLBI NIH HHS R01 HL071158NHLBI NIH HHS R01-HL071158Wellcome Trust 098565
6 · The paper itself

Abstract

Oxidative damage from elevated production of reactive oxygen species (ROS) contributes to ischemia-reperfusion injury in myocardial infarction and stroke. The mechanism by which the increase in ROS occurs is not known, and it is unclear how this increase can be prevented. A wide variety of nitric oxide donors and S-nitrosating agents protect the ischemic myocardium from infarction, but the responsible mechanisms are unclear. Here we used a mitochondria-selective S-nitrosating agent, MitoSNO, to determine how mitochondrial S-nitrosation at the reperfusion phase of myocardial infarction is cardioprotective in vivo in mice. We found that protection is due to the S-nitrosation of mitochondrial complex I, which is the entry point for electrons from NADH into the respiratory chain. Reversible S-nitrosation of complex I slows the reactivation of mitochondria during the crucial first minutes of the reperfusion of ischemic tissue, thereby decreasing ROS production, oxidative damage and tissue necrosis. Inhibition of complex I is afforded by the selective S-nitrosation of Cys39 on the ND3 subunit, which becomes susceptible to modification only after ischemia. Our results identify rapid complex I reactivation as a central pathological feature of ischemia-reperfusion injury and show that preventing this reactivation by modification of a cysteine switch is a robust cardioprotective mechanism and hence a rational therapeutic strategy.

Indexed as

AnimalsCysteineElectron Transport Complex IMaleMiceMice, Inbred C57BLMitochondria, HeartMitochondrial ProteinsMyocardial Reperfusion InjuryNitrosationProtein SubunitsRatsReactive Oxygen SpeciesCysteineElectron Transport Complex IMitochondrial ProteinsMT-ND3 protein, humanProtein SubunitsReactive Oxygen Species

Identifiers

PMID23708290
PMCPMC4019998
OpenAlexW1994270731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.